Devonian Health Group Inc. (TSXV:GSD)
Canada · Delayed Price · Currency is CAD 0.1900
0.00 (0.00%)
At close: Dec 16, 2025
Devonian Health Group Income Statement
Financials in millions CAD. Fiscal year is August - July.
Millions CAD. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 | 2016 - 2020 |
| 18.52 | 23.59 | 19.31 | 2.35 | 2.31 | 1.47 | Upgrade | |
Revenue Growth (YoY) | -23.01% | 22.19% | 723.15% | 1.74% | 56.32% | -31.19% | Upgrade |
Cost of Revenue | 11.41 | 15.03 | 11.83 | 1.45 | 1.74 | 1.72 | Upgrade |
Gross Profit | 7.11 | 8.56 | 7.48 | 0.89 | 0.56 | -0.24 | Upgrade |
Selling, General & Admin | 6.81 | 7.2 | 6.68 | 3.75 | 2.58 | 1.45 | Upgrade |
Research & Development | 1.97 | 2.01 | 1.29 | 1.35 | 0.78 | 0.61 | Upgrade |
Other Operating Expenses | 0.13 | 0.13 | 0.12 | 0.12 | 0.11 | - | Upgrade |
Operating Expenses | 8.91 | 9.33 | 8.09 | 5.22 | 3.47 | 2.07 | Upgrade |
Operating Income | -1.8 | -0.77 | -0.61 | -4.32 | -2.91 | -2.31 | Upgrade |
Interest Expense | -0.13 | -0.26 | -0.44 | -0.46 | -0.94 | -0.79 | Upgrade |
Interest & Investment Income | 0.23 | 0.28 | 0.07 | 0.18 | 0.04 | - | Upgrade |
Other Non Operating Income (Expenses) | - | - | - | - | 0.36 | -0.29 | Upgrade |
EBT Excluding Unusual Items | -1.7 | -0.75 | -0.98 | -4.6 | -3.45 | -3.39 | Upgrade |
Impairment of Goodwill | -4.64 | -4.64 | - | - | - | - | Upgrade |
Asset Writedown | -0.2 | -0.2 | - | - | - | - | Upgrade |
Other Unusual Items | - | - | - | - | - | 0.05 | Upgrade |
Pretax Income | -6.54 | -5.59 | -0.98 | -4.6 | -3.45 | -3.35 | Upgrade |
Income Tax Expense | 0.42 | 0.42 | 0.85 | - | - | - | Upgrade |
Net Income | -6.97 | -6.01 | -1.83 | -4.6 | -3.45 | -3.35 | Upgrade |
Net Income to Common | -6.97 | -6.01 | -1.83 | -4.6 | -3.45 | -3.35 | Upgrade |
Shares Outstanding (Basic) | 153 | 148 | 147 | 136 | 119 | 89 | Upgrade |
Shares Outstanding (Diluted) | 153 | 148 | 147 | 136 | 119 | 89 | Upgrade |
Shares Change (YoY) | 3.35% | 0.76% | 8.52% | 13.89% | 33.98% | 22.70% | Upgrade |
EPS (Basic) | -0.05 | -0.04 | -0.01 | -0.03 | -0.03 | -0.04 | Upgrade |
EPS (Diluted) | -0.05 | -0.04 | -0.01 | -0.03 | -0.03 | -0.04 | Upgrade |
Free Cash Flow | -6.22 | -1.27 | 5.64 | -4.36 | -2.95 | -1.83 | Upgrade |
Free Cash Flow Per Share | -0.04 | -0.01 | 0.04 | -0.03 | -0.03 | -0.02 | Upgrade |
Gross Margin | 38.40% | 36.28% | 38.74% | 38.05% | 24.34% | -16.34% | Upgrade |
Operating Margin | -9.70% | -3.27% | -3.18% | -184.37% | -126.35% | -156.37% | Upgrade |
Profit Margin | -37.61% | -25.49% | -9.46% | -196.11% | -149.59% | -226.92% | Upgrade |
Free Cash Flow Margin | -33.58% | -5.36% | 29.20% | -185.74% | -127.77% | -124.31% | Upgrade |
EBITDA | -1.46 | -0.38 | -0.22 | -3.92 | -2.07 | -1.3 | Upgrade |
EBITDA Margin | -7.87% | -1.62% | -1.14% | -167.35% | -89.81% | -87.87% | Upgrade |
D&A For EBITDA | 0.34 | 0.39 | 0.39 | 0.4 | 0.84 | 1.01 | Upgrade |
EBIT | -1.8 | -0.77 | -0.61 | -4.32 | -2.91 | -2.31 | Upgrade |
EBIT Margin | -9.70% | -3.27% | -3.18% | -184.37% | -126.35% | -156.37% | Upgrade |
Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.